首页> 外文期刊>The pharmaceutical journal >Insomnia disorder: management strategies
【24h】

Insomnia disorder: management strategies

机译:失眠症:管理策略

获取原文
获取原文并翻译 | 示例
           

摘要

In a previous article 'Insomnia disorder: diagnosis and prevention' (part 1), naturalistic sleep was examined as a physiological process and insomnia was discussed as a pathophysiological disordering of diis process, influenced by psychiatric, somatic and environmental factors. This article focuses on die clinical management of insomnia, presenting pharmacological and psychological strategies as different, yet not necessarily mutually exclusive, means of treating die disorder. Sleep disturbances have become increasingly common during the COV1D-19 pandemic owing to changes in work schedules, travel and exercise routines, as well as the concern and anxiety it may cause in some individuals. As a frontline profession in the pandemic, it is important that pharmacists understand how sleep disturbances should be managed and how to best counsel patients in this regard.
机译:在先前的“失眠症”:诊断和预防'(第1部分)中,被检查了自然主义睡眠作为生理过程,并且失眠被讨论了DIIS过程的病理生理失调,受到精神病学,体细胞和环境因素的影响。 本文重点介绍了失眠的临床管理,呈现不同的药理学和心理策略,但不一定是互斥的方式治疗死亡障碍。 由于工作时间表,旅行和锻炼惯例的变化以及它可能导致某些人可能导致的关注和焦虑,在COV1D-19大流行期间,睡眠障碍变得越来越普遍。 作为大流行的前线职业,药剂师认为应该如何管理睡眠障碍以及如何在这方面进行最佳咨询患者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号